Bao‐Ye Sun

528 total citations
22 papers, 370 citations indexed

About

Bao‐Ye Sun is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Bao‐Ye Sun has authored 22 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Molecular Biology and 6 papers in Immunology. Recurrent topics in Bao‐Ye Sun's work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). Bao‐Ye Sun is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers). Bao‐Ye Sun collaborates with scholars based in China, Ethiopia and India. Bao‐Ye Sun's co-authors include Yong Yi, Cheng Zhou, Ruo‐Yu Guan, Shuang‐Jian Qiu, Pei‐Yun Zhou, Gao Liu, Zhangfu Yang, Jia Fan, Zhu-Tao Wang and Jian Zhou and has published in prestigious journals such as Frontiers in Immunology, Cancer Letters and The American Journal of Surgery.

In The Last Decade

Bao‐Ye Sun

21 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bao‐Ye Sun China	12	169	136	104	77	70	22	370
Ranjan Prasad Devbhandari China	7	231 1.4×	152 1.1×	91 0.9×	48 0.6×	47 0.7×	10	457
Shenglan Huang China	11	150 0.9×	95 0.7×	69 0.7×	48 0.6×	60 0.9×	23	295
Luai Zarour United States	6	128 0.8×	85 0.6×	153 1.5×	72 0.9×	65 0.9×	9	353
Ruo‐Yu Guan China	13	202 1.2×	159 1.2×	128 1.2×	60 0.8×	144 2.1×	27	482
Zehua Wang China	13	275 1.6×	187 1.4×	185 1.8×	126 1.6×	33 0.5×	32	562
Wenxuan Xie China	10	231 1.4×	182 1.3×	85 0.8×	28 0.4×	50 0.7×	22	367
Nicole Liscia Italy	7	131 0.8×	104 0.8×	226 2.2×	73 0.9×	36 0.5×	29	374
Xueying Hou China	7	217 1.3×	90 0.7×	58 0.6×	43 0.6×	46 0.7×	14	371
Pina Ziranu Italy	12	200 1.2×	143 1.1×	251 2.4×	67 0.9×	48 0.7×	39	482
Dianke Chen China	13	299 1.8×	257 1.9×	186 1.8×	45 0.6×	54 0.8×	25	519

Countries citing papers authored by Bao‐Ye Sun

Since Specialization

Citations

This map shows the geographic impact of Bao‐Ye Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bao‐Ye Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bao‐Ye Sun more than expected).

Fields of papers citing papers by Bao‐Ye Sun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bao‐Ye Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bao‐Ye Sun. The network helps show where Bao‐Ye Sun may publish in the future.

Co-authorship network of co-authors of Bao‐Ye Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Bao‐Ye Sun. A scholar is included among the top collaborators of Bao‐Ye Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bao‐Ye Sun. Bao‐Ye Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Song, Yang, et al.. (2025). Gemcitabine-cisplatin chemotherapy plus anti-PD-L1 therapy reinvigorates antitumor immune response by reprogramming the intrahepatic cholangiocarcinoma microenvironment. Frontiers in Immunology. 16. 1666393–1666393.

Guan, Ruo‐Yu, Zhangfu Yang, Bao‐Ye Sun, et al.. (2024). Effective Antiviral Therapy Improves Immunosuppressive Activities in the Immune Microenvironment of Hepatocellular Carcinoma by Alleviating Inflammation and Fibrosis. Cancer Medicine. 13(23). e70459–e70459. 1 indexed citations

Sun, Bao‐Ye, Zhu-Tao Wang, Yang Song, et al.. (2024). Mobilization and activation of tumor-infiltrating dendritic cells inhibits lymph node metastasis in intrahepatic cholangiocarcinoma. Cell Death Discovery. 10(1). 304–304. 10 indexed citations

Zhou, Cheng, Bao‐Ye Sun, Yong Yi, et al.. (2024). Peripheral Lymphocytes in Primary Liver Cancers: Elevated NK and CD8+ T Cells and Dysregulated Selenium Metabolism. Biomolecules. 14(2). 222–222. 5 indexed citations

Gan, Wei, Bao‐Ye Sun, Zhangfu Yang, et al.. (2024). Enhancing hepatocellular carcinoma management: prognostic value of integrated CCL17, CCR4, CD73, and HHLA2 expression analysis. Journal of Cancer Research and Clinical Oncology. 150(6). 325–325. 3 indexed citations

Sun, Bao‐Ye, Wei Gan, Zhu-Tao Wang, et al.. (2024). Targeting CD73 limits tumor progression and enhances anti-tumor activity of anti-PD-1 therapy in intrahepatic cholangiocarcinoma. Journal of Cancer Research and Clinical Oncology. 150(7). 348–348. 6 indexed citations

Zhou, Cheng, Bao‐Ye Sun, Pei‐Yun Zhou, et al.. (2023). MAIT cells confer resistance to Lenvatinib plus anti-PD1 antibodies in hepatocellular carcinoma through TNF-TNFRSF1B pathway. Clinical Immunology. 256. 109770–109770. 20 indexed citations

Sun, Bao‐Ye, Zhangfu Yang, Zhu-Tao Wang, et al.. (2023). Integrative analyses identify CD73 as a prognostic biomarker and immunotherapeutic target in intrahepatic cholangiocarcinoma. World Journal of Surgical Oncology. 21(1). 90–90. 13 indexed citations

Zhou, Cheng, Zhangfu Yang, Bao‐Ye Sun, et al.. (2023). Lenvatinib Induces Immunogenic Cell Death and Triggers Toll-Like Receptor-3/4 Ligands in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 10. 697–712. 21 indexed citations

10.

Guan, Ruo‐Yu, Bao‐Ye Sun, Zhu-Tao Wang, et al.. (2022). Antiviral therapy improves postoperative survival of patients with HBV-related hepatocellular carcinoma. The American Journal of Surgery. 224(1). 494–500. 5 indexed citations

11.

Liu, Gao, Zhangfu Yang, Jian Sun, et al.. (2022). The LINC00152/miR-205-5p/CXCL11 axis in hepatocellular carcinoma cancer-associated fibroblasts affects cancer cell phenotypes and tumor growth. Cellular Oncology. 45(6). 1435–1449. 17 indexed citations

12.

Yi, Yong, Bao‐Ye Sun, Jialei Weng, et al.. (2022). Lenvatinib plus anti-PD-1 therapy represents a feasible conversion resection strategy for patients with initially unresectable hepatocellular carcinoma: A retrospective study. Frontiers in Oncology. 12. 1046584–1046584. 21 indexed citations

13.

Sun, Bao‐Ye, Ruo‐Yu Guan, Cheng Zhou, et al.. (2022). Deep-learning-based analysis of preoperative MRI predicts microvascular invasion and outcome in hepatocellular carcinoma. World Journal of Surgical Oncology. 20(1). 189–189. 16 indexed citations

14.

Sun, Bao‐Ye, Cheng Zhou, Ruo‐Yu Guan, et al.. (2022). Dissecting Intra-Tumoral Changes Following Immune Checkpoint Blockades in Intrahepatic Cholangiocarcinoma via Single-Cell Analysis. Frontiers in Immunology. 13. 871769–871769. 27 indexed citations

15.

Liu, Gao, Jian Sun, Zhangfu Yang, et al.. (2021). Cancer-associated fibroblast-derived CXCL11 modulates hepatocellular carcinoma cell migration and tumor metastasis through the circUBAP2/miR-4756/IFIT1/3 axis. Cell Death and Disease. 12(3). 260–260. 95 indexed citations

16.

Liu, Gao, Bao‐Ye Sun, Jian Sun, et al.. (2021). BRG1 regulates lipid metabolism in hepatocellular carcinoma through the PIK3AP1/PI3K/AKT pathway by mediating GLMP expression. Digestive and Liver Disease. 54(5). 692–700. 11 indexed citations

17.

Huang, Jinlong, Yi‐Peng Fu, Wei Gan, et al.. (2020). Hepatic stellate cells promote the progression of hepatocellular carcinoma through microRNA-1246-RORα-Wnt/β-Catenin axis. Cancer Letters. 476. 140–151. 53 indexed citations

18.

Liu, Gao, Zhangfu Yang, Pei‐Yun Zhou, et al.. (2020). ROR-α-1 inhibits the proliferation, invasion, and migration of hepatocellular carcinoma MHCC97H via downregulation of chemokine CXCL5. Cytokine. 129. 155004–155004. 15 indexed citations

19.

Yi, Yong, Xiaochun Ni, Liu Gao, et al.. (2020). Clinical significance of herpes virus entry mediator expression in hepatitis B virus‑related hepatocellular carcinoma. Oncology Letters. 20(4). 19–19. 8 indexed citations

20.

Sun, Bao‐Ye, Yantian Fang, Zhengyang Li, Zongyou Chen, & Jianbin Xiang. (2014). Advances in the application of nanotechnology in the diagnosis and treatment of gastrointestinal tumors. Molecular and Clinical Oncology. 3(2). 274–280. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact